131 related articles for article (PubMed ID: 38804869)
21. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.
Swann OV; Holden KA; Turtle L; Pollock L; Fairfield CJ; Drake TM; Seth S; Egan C; Hardwick HE; Halpin S; Girvan M; Donohue C; Pritchard M; Patel LB; Ladhani S; Sigfrid L; Sinha IP; Olliaro PL; Nguyen-Van-Tam JS; Horby PW; Merson L; Carson G; Dunning J; Openshaw PJM; Baillie JK; Harrison EM; Docherty AB; Semple MG;
BMJ; 2020 Aug; 370():m3249. PubMed ID: 32960186
[TBL] [Abstract][Full Text] [Related]
23. The Status of Pediatric Patients With Hematologic Malignancy During COVID-19 Pandemic in Wuhan City, China.
Wang Z; Shen Y; Jin R; Yu H; Zhou F; Xu J; Qiu Y; Wang L; Wu X
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e127-e133. PubMed ID: 33625077
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year.
Ward JL; Harwood R; Smith C; Kenny S; Clark M; Davis PJ; Draper ES; Hargreaves D; Ladhani S; Linney M; Luyt K; Turner S; Whittaker E; Fraser LK; Viner RM
Nat Med; 2022 Jan; 28(1):193-200. PubMed ID: 34931076
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 outcomes in hospitalized patients with active cancer: Experiences from a major New York City health care system.
Fu C; Stoeckle JH; Masri L; Pandey A; Cao M; Littman D; Rybstein M; Saith SE; Yarta K; Rohatgi A; Makarov DV; Sherman SE; Morrissey C; Jordan AC; Razzo B; Theprungsirikul P; Tsai J; Becker DJ
Cancer; 2021 Sep; 127(18):3466-3475. PubMed ID: 34096048
[TBL] [Abstract][Full Text] [Related]
26. COVID-19 in patients with Down syndrome.
Emami A; Javanmardi F; Akbari A; Asadi-Pooya AA
Neurol Sci; 2021 May; 42(5):1649-1652. PubMed ID: 33523318
[TBL] [Abstract][Full Text] [Related]
27. Severe COVID-19 in Vaccinated Adults With Hematologic Cancers in the Veterans Health Administration.
Anand ST; Vo AD; La J; Do NV; Fillmore NR; Brophy M; Branch-Elliman W; Monach PA
JAMA Netw Open; 2024 Feb; 7(2):e240288. PubMed ID: 38393725
[TBL] [Abstract][Full Text] [Related]
28. A Multimodal Lifestyle Psychosocial Survivorship Program in Young Cancer Survivors: The CARE for CAYA Program-A Randomized Clinical Trial Embedded in a Longitudinal Cohort Study.
von Grundherr J; Elmers S; Koch B; Hail LA; Mann J; Escherich G; Bergelt C; Samland L; Jensen W; Vettorazzi E; Stark M; Valentini L; Baumann FT; Singer S; Reer R; Beller R; Calaminus G; Faber J; Classen CF; Gebauer J; Hilgendorf I; Koehler M; Puzik A; Salzmann N; Sander A; Schiffmann L; Sokalska-Duhme M; Schuster S; Kock-Schoppenhauer AK; Bokemeyer C; Sinn M; Stein A; Dwinger S; Salchow J
JAMA Netw Open; 2024 Mar; 7(3):e242375. PubMed ID: 38526495
[TBL] [Abstract][Full Text] [Related]
29. Specific Susceptibility to COVID-19 in Adults with Down Syndrome.
Illouz T; Biragyn A; Frenkel-Morgenstern M; Weissberg O; Gorohovski A; Merzon E; Green I; Iulita F; Flores-Aguilar L; Dierssen M; De Toma I; Lifshitz H; Antonarakis SE; Yu E; Herault Y; Potier MC; Botté A; Roper R; Sredni B; Sarid R; London J; Mobley W; Strydom A; Okun E
Neuromolecular Med; 2021 Dec; 23(4):561-571. PubMed ID: 33660221
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.
Götzinger F; Santiago-García B; Noguera-Julián A; Lanaspa M; Lancella L; Calò Carducci FI; Gabrovska N; Velizarova S; Prunk P; Osterman V; Krivec U; Lo Vecchio A; Shingadia D; Soriano-Arandes A; Melendo S; Lanari M; Pierantoni L; Wagner N; L'Huillier AG; Heininger U; Ritz N; Bandi S; Krajcar N; Roglić S; Santos M; Christiaens C; Creuven M; Buonsenso D; Welch SB; Bogyi M; Brinkmann F; Tebruegge M;
Lancet Child Adolesc Health; 2020 Sep; 4(9):653-661. PubMed ID: 32593339
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 in children with haematological malignancies.
Millen GC; Arnold R; Cazier JB; Curley H; Feltbower R; Gamble A; Glaser A; Grundy RG; Kirton L; Lee LYW; McCabe MG; Palles C; Phillips B; Stiller CA; Varnai C; Kearns P
Arch Dis Child; 2022 Feb; 107(2):186-188. PubMed ID: 34301621
[TBL] [Abstract][Full Text] [Related]
32. Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative.
Song Q; Bates B; Shao YR; Hsu FC; Liu F; Madhira V; Mitra AK; Bergquist T; Kavuluru R; Li X; Sharafeldin N; Su J; Topaloglu U
J Clin Oncol; 2022 May; 40(13):1414-1427. PubMed ID: 35286152
[TBL] [Abstract][Full Text] [Related]
33. Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative.
Martin B; DeWitt PE; Russell S; Anand A; Bradwell KR; Bremer C; Gabriel D; Girvin AT; Hajagos JG; McMurry JA; Neumann AJ; Pfaff ER; Walden A; Wooldridge JT; Yoo YJ; Saltz J; Gersing KR; Chute CG; Haendel MA; Moffitt R; Bennett TD
JAMA Netw Open; 2022 Feb; 5(2):e2143151. PubMed ID: 35133437
[TBL] [Abstract][Full Text] [Related]
34. Risk for severe outcomes of COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany.
Sorg AL; Hufnagel M; Doenhardt M; Diffloth N; Schroten H; von Kries R; Berner R; Armann J
Eur J Pediatr; 2022 Oct; 181(10):3635-3643. PubMed ID: 35962242
[TBL] [Abstract][Full Text] [Related]
35. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
Simpson-Yap S; De Brouwer E; Kalincik T; Rijke N; Hillert JA; Walton C; Edan G; Moreau Y; Spelman T; Geys L; Parciak T; Gautrais C; Lazovski N; Pirmani A; Ardeshirdavanai A; Forsberg L; Glaser A; McBurney R; Schmidt H; Bergmann AB; Braune S; Stahmann A; Middleton R; Salter A; Fox RJ; van der Walt A; Butzkueven H; Alroughani R; Ozakbas S; Rojas JI; van der Mei I; Nag N; Ivanov R; Sciascia do Olival G; Dias AE; Magyari M; Brum D; Mendes MF; Alonso RN; Nicholas RS; Bauer J; Chertcoff AS; Zabalza A; Arrambide G; Fidao A; Comi G; Peeters L
Neurology; 2021 Nov; 97(19):e1870-e1885. PubMed ID: 34610987
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report.
McNerney KO; Richards RM; Aguayo-Hiraldo P; Calkoen FG; Talano JA; Moskop A; Balduzzi A; Krajewski J; Dave H; Vatsayan A; Callahan C; Liu H; Li Y; Davis KL; Maude SL
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36707090
[TBL] [Abstract][Full Text] [Related]
37. Prevention of COVID-19 infection in a pediatric oncology ward in Wuhan.
Zhang A; Hu Q; Liu A; Wang S; Jin S; Wang Y; Wang L; Hao Y
Pediatr Blood Cancer; 2020 Oct; 67(10):e28424. PubMed ID: 32779822
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies.
Chien KS; Peterson CB; Young E; Chihara D; Manasanch EE; Ramdial JL; Thompson PA
Blood Adv; 2023 Oct; 7(19):5691-5697. PubMed ID: 36696472
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
Rosenthal N; Cao Z; Gundrum J; Sianis J; Safo S
JAMA Netw Open; 2020 Dec; 3(12):e2029058. PubMed ID: 33301018
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic.
Čerňan M; Szotkowski T; Obr A; Látal V; Hluší A; Krhovská P; Klementová O; Kolář M; Sauer P; Faber E; Fürst T; Papajík T
Clin Lymphoma Myeloma Leuk; 2021 Sep; 21(9):606-612. PubMed ID: 34083176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
